focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.019
Bid: 0.018
Ask: 0.019
Change: -0.0002 (-1.04%)
Spread: 0.001 (5.556%)
Open: 0.0185
High: 0.019
Low: 0.0185
Prev. Close: 0.0192
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Loan Facility closes Agreement with Negma

2 Sep 2021 07:00

RNS Number : 5182K
Supply @ME Capital PLC
02 September 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

02 September 2021

 

Supply@ME Capital plc

(The "Company" or "SYME")

Supply@ME agrees new short-term loan facility to close Agreement with Negma Group

 

Supply@ME Capital plc, the innovative fintech platform which provides an Inventory Monetisation© service to manufacturing and trading companies, is pleased to announce it has signed a term sheet for a short-term loan facility with a family office investor, provided by ARC Group[1] ("ARC").

ARC Group is a global Investment Bank specialising in the middle markets, with representative offices across all continents. The Bank focuses on providing global fundraising solutions to its clients from institutional investors.

Subject to the execution of the definitive agreement, the short-term loan facility will replace the Subscription Agreement previously signed with Negma Group Ltd ("Negma Group"), as per the RNS of 16 June 2021. In relation to the Negma Group facility, the Company has made an application to the London Stock Exchange and the Financial Conduct Authority for admission to trading of 840,000,000 New Ordinary Shares (representing less than 3% of the Company's issued share capital) to be allotted to Negma Group. The remaining outstanding par value of the Convertible Loan Notes not yet converted is £2,106,000 and this residual portion is expected to be repaid in cash, funded by the new short-term loan facility.

Pursuant to the current contract executed with the Company, Negma Group:

- will not undertake any short sales of the Company's Ordinary Shares or any lending of the Company's Ordinary Shares;

- with respect to any disposal of Ordinary Shares on any given day, will not participate in more than twenty five percent (25%) of the daily Value Traded with respect to the Ordinary Shares on such day.

Loan conditions

The new agreement with the family office provided by ARC will help to ensure that the Company continues to be well capitalised and increases its balance sheet flexibility enabling its growth initiatives.

SYME has agreed to the following key terms for the facility:

· Initial tranche of £5 million, with a further £2 million available within 60 days;

· 12-month term, with an interest rate of 10%;

· Warrants will be issued for 20% of the £7 million loan value. The warrants will have a term of 3 years and exercise price of 130% of the lowest closing VWAP over the ten days immediately preceding the issue of the loan.

 

The ARC short-term loan facility will be linked to a Convertible Loan Note facility (CLN), should the Company require cash to facilitate further growth and need to trigger the facility.

 

At the same time SYME will work closely with ARC to further explore a dual listing on NASDAQ. In this regard, SYME will benefit from ARC's expertise in supporting foreign issuers on their journey onto NASDAQ and post-listing.

 

Alessandro Zamboni, CEO, Supply@ME Capital plc, said: "This is a key development for Supply@ME providing us with further flexibility to execute our plans and accelerate our expansion in key markets. ARC was impressed with our recent developments, confirmed by the recent trading update and the related revenue guidance. I am very pleased to strengthen our relationship with ARC at this important stage in our company's growth and I look forward to working with them closely as we further our efforts towards a dual listing. I would like to thank the Negma Group for the support provided which has enabled us to acquire TradeFlow and to support our recent growth initiatives as we move towards securing our first inventory monetisation transactions."

 

Jesús Emilio Hoyos, Managing Partner of ARC Group, said: "As the Financial Advisor to Supply@ME, we are very excited to facilitate this partnership between the Company and this Family Office. We believe that this is the beginning of great journey together and that the funds will help support the future growth of the Company."

 

Notes

The Company enables businesses to generate cashflow, via a non-credit approach and without incurring debt, by monetising their existing stock which is intended to be sold to end-customers or through monetisation of goods and or commodities as part of a typical import/ export transaction. SYME' Global Inventory Monetisation Fund enables creditworthy companies to improve their working capital cycle. The Fund does not target monetisation of inventories owned by companies in financial distress or otherwise seeking to monetise illiquid inventories.

 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

 

 

[1] https://www.arccap.us/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGGLKZVGMZG
Date   Source Headline
4th May 202312:40 pmRNSAdmission and Exercise of Open Offer Warrants
2nd May 202312:00 pmRNSSYME moves to SETS trading platform
28th Apr 20232:51 pmRNS2022 Annual Report and Accounts and Financing
26th Apr 20237:00 amRNSCommitment for first IM from traditional funding
13th Apr 202310:59 amRNSHolding(s) in Company
12th Apr 20235:38 pmRNSNotification of Transaction of a PCA
3rd Apr 202311:52 amRNSTotal Voting Rights
28th Mar 202311:05 amRNSSecond Price Monitoring Extn
28th Mar 202311:00 amRNSPrice Monitoring Extension
24th Mar 20234:40 pmRNSSecond Price Monitoring Extn
24th Mar 20234:35 pmRNSPrice Monitoring Extension
24th Mar 20237:30 amRNSBoard changes and TradeFlow update
20th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSDirectorate Change
3rd Mar 20234:32 pmRNSHolding(s) in Company
2nd Mar 20237:12 amRNSExercise of Warrants, issue of equity and TVR
1st Mar 20232:05 pmRNSSecond Price Monitoring Extn
1st Mar 20232:00 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSTotal Voting Rights
8th Feb 20235:07 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSTotal Voting Rights
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
24th Jan 20238:00 amRNSPublication of new Italian PNP regulation
20th Jan 20237:00 amRNSYear-end business update
10th Jan 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
30th Dec 202212:40 pmRNSSecond Price Monitoring Extn
30th Dec 202212:35 pmRNSPrice Monitoring Extension
30th Dec 20227:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSStrategic Alliance with VeChain Foundation
1st Dec 20227:00 amRNSExercise of Warrants, Issue of Equity & TVR
30th Nov 20227:00 amRNSTotal Voting Rights
22nd Nov 20227:00 amRNSExercise of Warrants, Issue of Equity, and TVR
7th Nov 20227:00 amRNSExercise of Warrants, Issue of Equity &TVR
2nd Nov 20227:00 amRNSGrant of Awards under Long Term Incentive Plan
2nd Nov 20227:00 amRNSTotal Voting Rights - Replacement
31st Oct 20223:07 pmRNSTotal Voting Rights
21st Oct 20222:01 pmRNSRepayment of Mercator Facility in Cash
21st Oct 20227:00 amRNSIssue of Equity
18th Oct 20225:51 pmRNSHolding in Company
14th Oct 20225:38 pmRNSHolding in Company
13th Oct 20227:00 amRNSNew Banking Facility
11th Oct 20228:00 amRNSHolding in Company
10th Oct 20227:00 amRNSAdmission of New Shares and Total Voting Rights
7th Oct 20221:30 pmRNSHolding in Company
3rd Oct 20222:06 pmRNSSecond Price Monitoring Extn
3rd Oct 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.